Assyro AI

Orange Book product · Brand (NDA)

ODOMZO

SONIDEGIB PHOSPHATE

Brand (NDA)NDA 205266RX SUN PHARM

At a glance

Jul 24, 2015

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 24, 2015

    11 yr 1 mo ago

  2. Today

  3. Patent 8178563 expires

    Listed drug substance patent expiration.

    Jul 24, 2029

    in 3 yr 2 mo

  4. Patent 8063043 expires

    Listed drug substance patent expiration.

    Sep 15, 2029

    in 3 yr 3 mo

  5. Patent 10266523 expires

    Listed drug substance patent expiration.

    Mar 30, 2036

    in 9 yr 11 mo

Pharmaceutical detail

Active ingredient

SONIDEGIB PHOSPHATE

Strength

EQ 200MG BASE

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 205266

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8178563Jul 24, 2029in 3 yr 2 mo
SubstanceU-1722
8063043Sep 15, 2029in 3 yr 3 mo
SubstanceProduct
10266523Mar 30, 2036in 9 yr 11 mo
SubstanceProduct
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.